A phase II clinical trial of chidamide in combination with toripalimab in patients with advanced soft tissue sarcoma

被引：0
|
作者：
Zhang, Xing
Peng, Ruiqing
Pan, Qiuzhong
Xu, Bushu
Hong, Dongchun
Que, Yi
机构：
[1] Sun Yat Sen Univ, Dept Med Melanoma & Sarcoma, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China,Canc Ctr, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Melanoma & Sarcoma Med Oncol Unit, Ctr Canc, Guangzhou, Peoples R China
[3] Sun Yat Sen Univ, Dept Med Melanoma & Sarcoma, State Key Lab Oncol South China, Collaborat Innovat Ctr Canc Med,Canc Ctr, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11566
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Isolated limb infusion (ILI)for patients with advanced extremity melanoma and soft tissue sarcoma. final report of a phase II trial
    Brady, M. S.
    Patel, A.
    Brown, K.
    Fisher, C.
    Marx, W.
    ANNALS OF SURGICAL ONCOLOGY, 2007, 14 (02) : 18 - 18
  • [42] Optimizing Clinical Care in Patients with Advanced Soft Tissue Sarcoma: A Phase II Study of a New Schedule of High-Dose Continuous Infusion Ifosfamide and Doxorubicin Combination
    De Pas, T.
    Rosati, G.
    Spitaleri, G.
    Boni, C.
    Tucci, A.
    Frustaci, S.
    Scalamogna, R.
    Radice, D.
    Boselli, S.
    Toffalorio, F.
    Catania, C.
    Noberasco, C.
    Delmonte, A.
    Vecchio, F.
    de Braud, F.
    CHEMOTHERAPY, 2011, 57 (03) : 217 - 224
  • [43] Phase II Study of Cediranib in Patients with Advanced Gastrointestinal Stromal Tumors or Soft-Tissue Sarcoma
    Judson, Ian
    Scurr, Michelle
    Gardner, Kate
    Barquin, Elizabeth
    Marotti, Marcelo
    Collins, Barbara
    Young, Helen
    Juergensmeier, Juliane M.
    Leahy, Michael
    CLINICAL CANCER RESEARCH, 2014, 20 (13) : 3603 - 3612
  • [44] Phase II study of 9-nitro-camptothecin in patients with advanced chordoma or soft tissue sarcoma
    Chugh, R
    Dunn, R
    Zalupski, MM
    Biermann, JS
    Sondak, VK
    Mace, JR
    Len, KM
    Chandler, WF
    Baker, LH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3597 - 3604
  • [45] In search of effective therapies: the current landscape of phase II trials in patients with advanced soft tissue sarcoma
    Paweł Sobczuk
    Huber Bątruk
    Paulina Wójcik
    Krzysztof Iwaniak
    Katarzyna Kozak
    Piotr Rutkowski
    Journal of Cancer Research and Clinical Oncology, 2023, 149 : 2771 - 2782
  • [46] In search of effective therapies: the current landscape of phase II trials in patients with advanced soft tissue sarcoma
    Sobczuk, Pawel
    Batruk, Huber
    Wojcik, Paulina
    Iwaniak, Krzysztof
    Kozak, Katarzyna
    Rutkowski, Piotr
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (07) : 2771 - 2782
  • [47] A phase II trial of AP23573, a novel mTOR inhibitor, in patients (Pts) with advanced soft tissue or bone sarcoma.
    Chawla, SP
    Blay, JY
    Staddon, AP
    D'Amato, GZ
    Tolcher, AW
    Sankhala, KK
    Daly, ST
    Bedrosian, CL
    Demetri, GD
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9166S - 9166S
  • [48] Randomized Phase 2 Clinical Trial of Olaratumab in Combination with Gemcitabine and Docetaxel in Advanced Soft Tissue Sarcomas
    Attia, Steven
    Villalobos, Victor
    Hindi, Nadia
    Wagner, Andrew J.
    Chmielowski, Bartosz
    Oakley, Gerard J.
    Peterson, Patrick M.
    Ceccarelli, Matteo
    Jones, Robin L.
    Dickson, Mark A.
    CANCERS, 2023, 15 (19)
  • [49] Perceptions of clinical trial enrollment in patients with bone and soft tissue sarcoma
    Rosenberg, A.
    Kircher, S.
    Hahn, E.
    Rademaker, A.
    Bilimoria, K.
    Wayne, J. D.
    Agulnik, M.
    ANNALS OF ONCOLOGY, 2018, 29
  • [50] Phase II trial of tamoxifen and interferon alpha in patients with metastatic or recurrent soft tissue sarcoma.
    Kyasa, MJ
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 825S - 825S
12345